Israel
· Delayed Price · Currency is ILS · Price in ILA TLV: REKA Company Description
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel.
The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations.
Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-inflammatories, cough, expectoration and bronchitis, motion sickness, runny nose and congestion, skin disinfection, wounds, burns and insect bites, fever and pain relief, mouth, depression and anxiety, muscle and joint pain, anemia and nutritional deficits, ear pain, babies and children etc. Rekah Pharmaceutical Industry Ltd. was founded in 1947 and is based in Holon, Israel.
| Country | Israel |
| Founded | 1947 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 427 |
| CEO | Mordechai Elgrabli |
Contact Details
Address: 30 Hamelacha Street Holon, 5881904 Israel | |
| Phone | 972 3 558 1233 |
| Website | rekah.co.il |
Stock Details
| Ticker Symbol | REKA |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0010810096 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yaakov Elgrabli | Chief Executive Officer of Ophir and Shalpharm Ltd |
| Yuval Elgrabli | Deputy Chief Executive Officer and Director of Business Development |
| Nir Sella | Chief Executive Officer - Fresh of Life Pharma Ltd. |
| Jacob Elgrably | Chief Executive Officer of Ophir Shalpharm |
| Mordechai Elgrabli | Chief Executive Officer and Director |
| Georgette Elgrabli | Director of Industrial Division and Director |
| Meir Melumad | Director of Operations |